| 2010 | A case of combined hepatocellular-cholangiocarcinoma with favorable response to systemic chemotherapy
| CANCER RESEARCH AND TREATMENT |
| 2007 | A Locally Advanced Breast Cancer with Difficult Differential Diagnosis of Carcinosarcoma and Atypical Medullary Carcinoma, which had Poor Response to Adriamycin- and ...
| CANCER RESEARCH AND TREATMENT |
| 2022 | A multi-institutional, single-arm, phase II trial of neoadjuvant modified-FOLFIRINOX for resectable pancreatic ductal adenocarcinoma | JOURNAL OF CLINICAL ONCOLOGY |
| 2022 | A novel anti-cancer compound development targeting YAP-TEAD protein-protein interaction | EUROPEAN JOURNAL OF CANCER |
| 2010 | A phase I pharmacokinetic and pharmacodynamic study of CKD-732, an antiangiogenic agent, in patients with refractory solid cancer | INVESTIGATIONAL NEW DRUGS |
| 2012 | A phase I pharmacokinetic study of TSU-68 (a multiple tyrosine kinase inhibitor of VEGFR-2, FGF and PDFG) in combination with S-1 and oxaliplatin in metastatic colorectal cancer patients previously treated with chemotherapy. | INVESTIGATIONAL NEW DRUGS |
| 2009 | A phase II feasibility study of weekly paclitaxel in heavily pretreated advanced gastric cancer patients with poor performance status | ONCOLOGY |
| 2010 | A phase II study of a combined biweekly irinotecan and monthly cisplatin treatment for metastatic or recurrent gastric cancer. | AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS |
| 2006 | A Phase II Study of Infusional 5-Fluorouracil and Low-Dose Leucovorin with Docetaxel for Advanced Gastric Cancer | ONCOLOGY |
| 2008 | A phase II study of paclitaxel combined with infusional 5-fluorouracil and low-dose leucovorin for advanced gastric cancer. | CANCER CHEMOTHERAPY AND PHARMACOLOGY |
| 2007 | A phase II study of S-1 monotherapy administered for 2 weeks of a 3-week cycle in advanced gastric cancer patients with poor performance status
| BRITISH JOURNAL OF CANCER |
| 2006 | A phase II trial of S-1 monotherapy in metastatic colorectal cancer after failure of irinotecan- and oxaliplatin-containing regimens
| BRITISH JOURNAL OF CANCER |
| 2007 | A phase II trial of weekly fractionated irinotecan and cisplatin for advanced gastric cancer | CANCER CHEMOTHERAPY AND PHARMACOLOGY |
| 2012 | A pilot study of S-1 plus cisplatin versus 5-fluorouracil plus cisplatin for postoperative chemotherapy in histological stage IIIB-IV (M0) gastric cancer | INVESTIGATIONAL NEW DRUGS |
| 2011 | A prognostic model to predict clinical outcome in gastric cancer patients with bone metastasis | ONCOLOGY |
| 2011 | A randomized phase 2 study of docetaxel and S-1 versus docetaxel and cisplatin in advanced gastric cancer with an evaluation of SPARC expression for personalized therapy
| CANCER |
| 2022 | A single arm phase Ib/II trial of first-line pembrolizumab, trastuzumab and chemotherapy for advanced HER2-positive gastric cancer
| NATURE COMMUNICATIONS |
| 2017 | ABCB1 2677G>T/A variant enhances chemosensitivity to anti-cancer agents acting on microtubule dynamics through LAMP1 inhibition | BIOCHEMICAL PHARMACOLOGY |
| 2001 | Adjuvant 5-fluorouracil plus doxorubicin in D2-3 resected gastric carcinoma: 15-year experience at a single institute. | CANCER |
| 2011 | Advanced detection of recent changing trends in gastric cancer survival: up-to-date comparison by period analysis.
| JAPANESE JOURNAL OF CLINICAL ONCOLOGY |
| 2006 | Alteration of hTERT full-length variant expression level showed different gene expression profiles and genomic copy number changes in breast cancer | ONCOLOGY REPORTS |
| 2007 | An association between RRM1 haplotype and gemcitabine-induced neutropenia in breast cancer patients
| ONCOLOGIST |
| 2007 | An Attempt for Combining Microarray Data Sets by Adjusting Gene Expressions
| CANCER RESEARCH AND TREATMENT |
| 2014 | Angiogenic factor thymidine phosphorylase associates with angiogenesis and lymphangiogenesis in the intestinal-type gastric cancer | PATHOLOGY |
| 2008 | Angiogenic factor thymidine phosphorylase increases cancer cell invasion activity in patients with gastric adenocarcinoma.
| MOLECULAR CANCER RESEARCH |
| 2017 | ANO9/TMEM16J promotes tumourigenesis via EGFR and is a novel therapeutic target for pancreatic cancer | BRITISH JOURNAL OF CANCER |
| 2000 | Anthracycline 의 치료력이 있는 전이성 유방암에 대한 Docetaxel 의 제 2 상 다기관 임상시험
| Journal of the Korean Cancer Association (대한암학회지) |
| 2007 | Anti-tumor activity of N-hydroxy-7-(2-naphthylthio) heptanomide, a novel histone deacetylase inhibitor | BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS |
| 2013 | Application of the Adjuvant! Online Model to Korean Breast Cancer Patients: An Assessment of Prognostic Accuracy and Development of an Alternative Prognostic Tool | ANNALS OF SURGICAL ONCOLOGY |
| 2021 | Association between Skeletal Muscle Loss and the Response to Neoadjuvant Chemotherapy for Breast Cancer
| CANCERS |
| 2010 | Association of the ABCB1 3435C>T polymorphism and treatment outcomes in advanced gastric cancer patients treated with paclitaxel-based chemotherapy. | ONCOLOGY REPORTS |
| 2009 | Association of the ABCB1 gene polymorphisms 2677G>T/A and 3435C>T with clinical outcomes of paclitaxel monotherapy in metastatic breast cancer patients
| ANNALS OF ONCOLOGY |
| 2005 | Attenuation of telomerase activity by hammerhead ribozyme targeting human telomerase RNA induces growth retardation and apoptosis in human breast tumor cells | INTERNATIONAL JOURNAL OF CANCER |
| 2009 | Benefits of recurrent colonic stent insertion in a patient with advanced gastric cancer with carcinomatosis causing colonic obstruction
| YONSEI MEDICAL JOURNAL |
| 2007 | Bilateral Breast Cancer: Differential Diagnosis Using Histological and Biological Parameters
| JAPANESE JOURNAL OF CLINICAL ONCOLOGY |
| 2002 | Biological phenotype determination with ex vivo model in gastric cancer for matrix-metalloproteinase inhibitor treatment. | INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE |
| 2012 | Body fluid MMP-2 as a putative biomarker in metastatic breast cancer
| ONCOLOGY LETTERS |
| 2008 | Capecitabine and doxorubicin combination chemotherapy as salvage therapy in pretreated advanced gastric cancer. | CANCER CHEMOTHERAPY AND PHARMACOLOGY |
| 2007 | Cetuximab rescue a patient with non-small cell lung cancer from rapid disease progression during chemotherapy | ACTA ONCOLOGICA |
| 2017 | Changes in telomerase activity due to alternative splicing of human telomerase reverse transcriptase in colorectal cancer
| ONCOLOGY LETTERS |
| 2009 | Changes of telomerase activity by alternative splicing of full-length and beta variants of hTERT in breast cancer patients. | ONCOLOGY RESEARCH |
| 2007 | Changing patterns of prognosticators during 15-year follow-up of advanced gastric cancer after radical gastrectomy and adjuvant chemotherapy: A 15-year follow-up study at a single korean institute | ANNALS OF SURGICAL ONCOLOGY |
| 2010 | Chemokine growth-regulated oncogene 1 as a putative biomarker for gastric cancer progression | CANCER SCIENCE |
| 2010 | Circulating endothelial progenitor cells (EPC) for tumor vasculogenesis in gastric cancer patients | CANCER LETTERS |
| 2009 | Copy number changes can be a predictor for hemoglobin reduction after S-1 monotherapy in gastric cancer | INTERNATIONAL JOURNAL OF ONCOLOGY |
| 2005 | Cyclic induction of senescence with intermittent AZT treatment accelerates both apoptosis and telomere loss | BREAST CANCER RESEARCH AND TREATMENT |
| 2013 | Difference of interferon-α and interferon-β on melanoma growth and lymph node metastasis in mice | MELANOMA RESEARCH |
| 2007 | Different criteria for HER2 positivity by IHC can be applied in post-chemotherapy specimens in determining HER2 as a prognosticator in locally advanced breast cancer | BREAST CANCER RESEARCH AND TREATMENT |
| 2005 | Different role of functional domains of hTR in DNA binding to telomere and telomerase reconstruction
| FEBS LETTERS |
| 2012 | Differential expression patterns of MMPs and their role in the invasion of epithelial premalignant tumors and invasive cutaneous squamous cell carcinoma. | EXPERIMENTAL AND MOLECULAR PATHOLOGY |
| 2017 | Differential Prognostic Implications of Gastric Signet Ring Cell Carcinoma: Stage Adjusted Analysis From a Single High-volume Center in Asia
| ANNALS OF SURGERY |
| 2009 | Docetaxel versus paclitaxel combined with 5-FU and leucovorin in advanced gastric cancer: combined analysis of two phase II trials.
| CANCER RESEARCH AND TREATMENT |
| 2010 | Efficacy and feasibility of radiofrequency ablation for liver metastases from gastric adenocarcinoma | INTERNATIONAL JOURNAL OF HYPERTHERMIA |
| 2018 | Efficacy of adjuvant chemotherapy for completely resected stage IB non-small cell lung cancer: a retrospective study
| JOURNAL OF THORACIC DISEASE |
| 2001 | Efficacy of Pre - and Postoperative Chemotherapy in Patients with Osteosarcoma of the Extremities
| CANCER RESEARCH AND TREATMENT |
| 2012 | Epigenetic therapy using belinostat for patients with unresectable hepatocellular carcinoma: a multicenter phase I/II study with biomarker and pharmacokinetic analysis of tumors from patients in the Mayo Phase II Consortium and the Cancer Therapeutics Research Group | JOURNAL OF CLINICAL ONCOLOGY |
| 2012 | FKBP5 polymorphisms as vulnerability to anxiety and depression in patients with advanced gastric cancer: a controlled and prospective study | PSYCHONEUROENDOCRINOLOGY |
| 2018 | Forty-nine gastric cancer cell lines with integrative genomic profiling for development of c-MET inhibitor | INTERNATIONAL JOURNAL OF CANCER |
| 2009 | G-T haplotype (2677G>T/A and 3435C>T) of ABCB1 gene polymorphisms is associated with ethnic differences to paclitaxel sensitivity in cancer cells with different gene expression pattern | CANCER LETTERS |
| 2012 | Gemcitabine and oxaliplatin with or without erlotinib in advanced biliary-tract cancer: a multicentre, open-label, randomised, phase 3 study. | LANCET ONCOLOGY |
